Delivery Order SPE2DB25D3202-SPE2DB25FTBBJ
- Not listed
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $53,049.32 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count units) on April 21, 2025, with an ultimate completion date of April 22, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a routine pharmaceutical procurement supporting...
- The Defense Logistics Agency awarded a $3,354.92 delivery order to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on July 30, 2025, with a completion date of July 31, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation represents a pharmaceutical supply delivery to support federal medical procurement needs. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $66,837.85 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price delivery order carries no set-aside designation and will be performed at the contractor's Conshohocken, Pennsylvania location. The award represents a routine pharmaceutical procurement transaction typical of the agency's ongoing medical supply chain...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $22,419.07 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) on August 1, 2025. This firm fixed-price delivery order, which is part of a non-set-aside competitive procurement, is scheduled for completion by August 4, 2025, with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order represents a routine pharmaceutical...
- The Defense Logistics Agency awarded a delivery order valued at $3,107.17 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count packaging) on June 2, 2025, with an ultimate completion date of June 3, 2025. This is a firm fixed-price delivery order with no set-aside designation, indicating competitive award. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child order under a larger contract vehicle, this delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $13,515.86 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (8-count) on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a pharmaceutical supply to support federal medical procurement needs. The place of performance is listed as AmerisourceBergen's corporate office in Conshohocken, Pennsylvania....
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $13,404.62 to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count units). This firm fixed-price, competitively awarded delivery order was issued on September 8, 2025, with an ultimate completion date of September 9, 2025. The pharmaceutical products will be delivered to the Conshohocken, Pennsylvania location, where AmerisourceBergen maintains its corporate headquarters. This delivery order is...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp for the supply of NURTEC ODT 75 mg tablets (8-count packages) with a ceiling value of $14,675.36. This firm fixed-price delivery order, awarded on June 30, 2025, with a completion date of July 1, 2025, represents a competitive procurement with no set-aside designation. The pharmaceutical product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $8,446.64 to AmerisourceBergen Drug Corp on May 8, 2025, for the supply of NURTEC ODT 75 mg tablets (8-count package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of May 9, 2025. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order represents a discrete purchase under the company's broader...
- The Defense Logistics Agency awarded a delivery order valued at $3,258.15 to AmerisourceBergen Drug Corp for NURTEC ODT 75 MG tablets (8-count) on September 11, 2025, with completion scheduled for September 12, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation to the pharmaceutical distributor's corporate office located in Conshohocken, Pennsylvania. The contract represents a routine pharmaceutical supply transaction within AmerisourceBergen's...
- SPE2DB25D3202Indefinite Delivery Contract
- SPE2DB25D3202-SPE2DB25FTBBJDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $7,893.98 to AmerisourceBergen Drug Corp for NURTEC ODT 75 mg tablets (quantity: 8 packs) on August 1, 2025, with completion targeted for August 4, 2025. This firm fixed-price, competitively awarded delivery order was issued without set-aside designation and will be fulfilled from the vendor's facility in Conshohocken, Pennsylvania. The award represents a standard pharmaceutical supply transaction supporting federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. This comprehensive prime contract vehicle enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies—including brand-name and generic medications, vaccines, and specialized healthcare commodities—to support military healthcare systems globally. The contract serves multiple federal customers including the Defense Health Agency and U.S. Coast Guard, positioning AmerisourceBergen as a critical vendor within the DLA's pharmaceutical supply chain supporting Department of Defense medical operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $7.9k | 8/1/25 |